Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment.
Recombinant DNA risk assessment studies quantitated the mobilizability of "safe" plasmid pBR325, in comparison with readily mobilizable plasmid pJBK5 (chloramphenicol and tetracycline resistant). Of 15 volunteers who became colonized after ingestion of 5 X 10(10) Escherichia coli HS-4, a normal human flora strain containing pJBK5 and daily oral tetracycline, nine manifested transfer of pJBK5 to normal flora by means of triparental mating. In contrast, none of 12 other volunteers cocolonized with HS-4 bearing "safe" pBR325 and normal flora showed transfer (P = 0.001), despite ingestion of tetracycline. To accomplish transfer directly, E coli HS-4 containing both pBR325 and a derepressed, conjugative plasmid (F-amp) was fed to two groups of volunteers. Transfer of pBR325 to normal flora occurred in 13 of 18 volunteers taking daily tetracycline but in none of eight who did not (P less than 0.002). Nor were transconjugants detected, despite tetracycline ingestion, in five volunteers who ingested and excreted E coli K12 (pBR325 plus F-amp).
D000328:Adult; D003001:Cloning, Molecular / Q000379:methods; D003106:Colon / Q000382:microbiology; D003227:Conjugation, Genetic; D003264:Containment of Biohazards; D004274:DNA, Recombinant / Q000009:adverse effects*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000235:genetics; D005243:Feces / Q000382:microbiology; D005798:Genes, Bacterial; D006801:Humans; D010957:Plasmids; D012306:Risk; D013752:Tetracycline / Q000008:administration & dosage / Q000037:antagonists & inhibitors
D004274:DNA, Recombinant; D013752:Tetracycline